As estimated, the patients with breast cancer who received 4 or more cycles of chemotherapy exhibited decreased serum estrogen levels and increased serum FSH levels reflecting the disordered ovarian function compared to that in the general population with correspondent age. The gene discussed is BRD2; the disease is breast carcinoma.